Biologic Patent Protection: When Biosimilars Can Enter the U.S. Market
Biologic patent protection in the U.S. delays biosimilar entry for up to 12 years, keeping drug prices high. Learn why biosimilars take longer to launch than generics and how patent thickets and complex regulations hurt patients.
